How to select the optimal therapy for early-stage prostate cancer Journal Article


Authors: Kollmeier, M. A.; Zelefsky, M. J.
Article Title: How to select the optimal therapy for early-stage prostate cancer
Abstract: Selecting the " optimal therapy" for the patient with localized prostate cancer may be one of the most challenging medical decisions facing the oncologist. Most patients will have a number of appropriate therapeutic options available to them. Before determining which therapy is most appropriate for a patient, a critical question which needs to be asked is whether any therapy is necessary, especially for those who present with early-stage, low-grade, low-volume disease. Furthermore, given the lack of randomized trials available to guide physicians regarding the superiority of one therapy over another, it is important to consider the different side-effect profiles relevant for each treatment modality. The potential toxicities of therapy impact quality-of-life outcomes and play an important role for most patients in their individual selection of a particular therapy. In addition, there are other important issues that need to be considered, which include the medical condition of the patient and emotional and psychological considerations, as well as family/peer viewpoints or perceived notions of a particular therapy. This review will discuss the relevant issues in the decision making and treatment selection for the patient. © 2011 Elsevier Ireland Ltd.
Keywords: treatment outcome; review; intensity modulated radiation therapy; cancer adjuvant therapy; cancer radiotherapy; cancer staging; nuclear magnetic resonance imaging; diagnostic accuracy; laparoscopic surgery; prostate specific antigen; quality of life; tumor volume; cancer screening; cancer therapy; prostate cancer; gastrointestinal toxicity; early cancer; prostatectomy; high intensity focused ultrasound; brachytherapy; nuclear magnetic resonance spectroscopy; surgery; clinical decision making; patient decision making; external beam radiotherapy; urogenital tract disease; patient counseling; patient referral; receiver operating characteristic; cryotherapy; disease surveillance; treatment selection
Journal Title: Critical Reviews in Oncology/Hematology
Volume: 84
Issue: Suppl. 1
ISSN: 1040-8428
Publisher: Elsevier Science, Inc.  
Date Published: 2012-12-01
Start Page: e6
End Page: e15
Language: English
DOI: 10.1016/j.critrevonc.2012.12.002
PROVIDER: scopus
PUBMED: 23273666
DOI/URL:
Notes: --- - "Export Date: 1 February 2013" - "CODEN: CCRHE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael J Zelefsky
    754 Zelefsky
  2. Marisa A Kollmeier
    229 Kollmeier